Lineage Cell Therapeutics, Inc. (TLV:LCTX)
Israel · Delayed Price · Currency is ILS · Price in ILA 581.90
+6.20 (1.08%)
At close: Jan 9, 2026
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of 1.31 billion as of January 9, 2026. Its market cap has increased by 194.41% in one year.
Market Cap
1.31B
Enterprise Value
1.18B
Revenue
35.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
581.90
Market Cap Chart
Since May 1, 1992, Lineage Cell Therapeutics's market cap has increased from 49.45M to 1.31B, an increase of 2,541.67%. That is a compound annual growth rate of 10.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.31B | 1.25% |
| Dec 31, 2025 | 1.29B | 219.80% |
| Dec 31, 2024 | 403.42M | -41.27% |
| Dec 29, 2023 | 686.90M | -1.77% |
| Dec 30, 2022 | 699.29M | -45.56% |
| Dec 31, 2021 | 1.28B | 51.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 118.47B |
| Danel (Adir Yeoshua) | 2.92B |
| Kamada | 1.47B |
| BrainsWay | 1.43B |
| SofWave Medical | 1.19B |
| Bait Bakfar | 1.06B |
| Ilex Medical | 769.85M |
| Novolog (Pharm-Up 1966) | 653.41M |